Rate My Professor Charles Malpas

Associate Professor Charles Malpas is a clinical neuropsychologist, applied statistician, and educator holding appointments as Associate Professor in the Melbourne School of Psychological Sciences and the Melbourne Medical School at the University of Melbourne. He earned his Bachelor of Arts in Psychology and Criminology, Bachelor of Arts (Honours) in Psychology, Master of Psychology (Clinical Neuropsychology), and Doctor of Philosophy in Clinical Neuropsychology from the University of Melbourne, along with a Graduate Certificate in Applied Statistics from Swinburne University. Completing his clinical training and PhD in Alzheimer's disease research at the University of Melbourne, he undertook a clinical fellowship in epilepsy neuropsychology at the Royal Melbourne Hospital. His career includes roles as Honorary Clinical Neuropsychologist at the Royal Melbourne Hospital since 2016, Adjunct Associate Professor in the School of Translational Medicine at Monash University since 2019, and consultant neuropsychologist at the Royal Melbourne Hospital and Alfred Health. He serves as Associate Editor for BJPsych Open and leads the Cognitive Disorders Research Group, focusing on the neuropsychology of seizure disorders, neurodegenerative diseases, and neuroinflammatory conditions.

Malpas's research specializes in cognitive outcomes in epilepsy, multiple sclerosis, autoimmune encephalitis, and dementia, with over 300 publications and more than 6,500 citations on Google Scholar. Key works include 'Validation of the Seizure-Related Impact Assessment Scale (SERIAS)' (2024), 'Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis' (2026), 'Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy' (2026), and 'The topography of infratentorial lesions in depression and anxiety in multiple sclerosis' (2025). He has received an NHMRC Early Career Fellowship (2017-2018) and a Royal Melbourne Hospital Post-Doctoral Fellowship ($165,000) for multiple sclerosis cognitive impairment research. His contributions advance diagnosis and management of cognitive disorders through collaborations with Royal Melbourne Hospital Neurology, Melbourne Health Neuropsychiatry, and Monash University Neuroscience, influencing clinical practice in neuroimmunology, epilepsy, and neuropsychiatry.